Ashik Kurian analyst CITI

Currently out of the existing stock ratings of Ashik Kurian, 12 are a BUY (75%), 4 are a HOLD (25%).

Ashik Kurian

Work Performance Price Targets & Ratings Chart

Analyst Ashik Kurian, currently employed at CITI, carries an average stock price target met ratio of 46.67% that have a potential upside of 20.17% achieved within 286 days.

Ashik Kurian’s has documented 33 price targets and ratings displayed on 3 stocks. The coverage is on the Consumer Cyclical sector.

Most recent stock forecast was given on MRSN, Mersana Therapeutics at 15-Nov-2024.

Wall Street Analyst Ashik Kurian

Analyst best performing recommendations are on GT (GOODYEAR TIRE & RUBBER CO).
The best stock recommendation documented was for GT (GOODYEAR TIRE & RUBBER CO) at 3/30/2020. The price target of $7.5 was fulfilled within 10 days with a profit of $1.58 (26.69%) receiving and performance score of 26.69.

Average potential price target upside

ALV Autoliv GT Goodyear Tire & Rubber Co MRSN Mersana Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$97

$2.29 (2.42%)

$101

12 days ago
(16-Dec-2024)

21/26 (80.77%)

$0.98 (1.02%)

156

Hold

$108

$13.29 (14.03%)

$111

2 months 7 days ago
(21-Oct-2024)

12/16 (75%)

$11.2 (11.57%)

218

Hold

$110

$15.29 (16.14%)

$115

2 months 13 days ago
(15-Oct-2024)

8/10 (80%)

$16.33 (17.43%)

38

Buy

$116

$21.29 (22.48%)

$113

3 months 18 days ago
(10-Sep-2024)

21/22 (95.45%)

$21.96 (23.35%)

313

Buy

$120

$25.29 (26.70%)

$133

3 months 23 days ago
(05-Sep-2024)

4/6 (66.67%)

$20.86 (21.04%)

508

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Ashik Kurian is most bullish on?

Potential upside of $3.5 has been obtained for MRSN (MERSANA THERAPEUTICS)

What Year was the first public recommendation made by Ashik Kurian?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?